Mechanical Prosthetic Valve Thrombosis: Case Report and Review of the Literature

被引:0
作者
Bruce D. Klugherz
Howard C. Herrmann
机构
[1] University of Pennsylvania Medical Center,Cardiovascular Division, Department of Medicine
来源
Journal of Thrombosis and Thrombolysis | 1998年 / 6卷
关键词
prosthetic valve; thrombosis; valve replacement; thrombolysis;
D O I
暂无
中图分类号
学科分类号
摘要
Mechanical prosthetic valve thrombosis is a life-threatening complication necessitating immediate intervention. The presenting signs and symptoms of this illness are somewhat variable, but physical examination and transesophageal echocardiography enable rapid diagnosis. To avoid catastrophic complications, valve replacement or debridement, or thrombolysis in the correct setting, must be performed without delay. It is not entirely clear which therapy is superior. For any given patient, the risks of thrombolytic therapy, including bleeding, systemic embolism, and failure to restore valvular function, must be weighed against the risks of surgical intervention. Once the decision is made to operate, the choice of valve replacement versus debridement is one best made intraoperatively, upon visual inspection of the valve apparatus. Despite aggressive therapy, morbidity and mortality from prosthetic valve thrombosis and its treatment are not trivial. Fortunately, with current prosthetic devices and aggressive prophylactic anticoagulation, the incidence of prosthetic valve thrombosis remains low. Antiplatelet therapy may offer additional benefit to patients being prophylaxed with warfarin. This report details the case of a woman with aortic and mitral prosthetic valves who presented with heart failure and evidence of severe aortic prosthetic dysfunction after a period of suboptimal anticoagulation. She successfully underwent debridement of the mitral prosthesis and replacement of the aortic valve. The relevant literature is reviewed.
引用
收藏
页码:253 / 259
页数:6
相关论文
共 163 条
[1]  
Edmunds LH(1988)Guidelines for reporting morbidity and mortality after cardiac valvular operations Ann Thorac Surg 46 257-259
[2]  
Clark RE(1993)Reoperations on prosthetic heart valves: An analysis of outcome Artif Organs 17 791-796
[3]  
Cohn LH(1994)Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses Circulation 89 635-641
[4]  
Miller DC(1983)Ten to fifteen year reassessment of the performance characteristics of the Starr–Edwards Model 6120 mitral valve prosthesis J Thorac Cardiovasc Surg 85 1-20
[5]  
Weisel RD.(1984)Aortic and mitral valve incompetence: Long-term follow-up (10 to 19 years) of patients treated with the Starr-Edwards prosthesis J Am Coll Cardiol 3 930-938
[6]  
Otaki M(1982)Thromboembolic complications of current cardiac valvular prostheses Ann Thorac Surg 34 96-106
[7]  
Kitamura N.(1984)The risk of thromboembolism following valvular operations: How does one know? J Thorac Cardiovasc Surg 88 782-786
[8]  
Cannegieter SC(1991)Obstruction of mechanical heart valve prostheses: Clinical aspects and surgical management J Am Coll Cardiol 17 646-650
[9]  
Rosendaal FR(1992)Mechanical cardiac valve thrombosis: Is fibrinolysis justified? Circulation 86 8-15
[10]  
Briet E.(1989)Thrombotic obstruction of disc valves: Clinical recognition and surgical management Ann Thorac Surg 48 60-65